局部进展性和转移性肾癌外科治疗现状
被引量:3
Current Status of Surgical Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma
摘要
文章主要阐述了外科手术在治疗局部进展性和转移性肾癌中的价值,分别对区域淋巴结转移、肾上腺转移、静脉瘤栓、邻近器官受侵以及转移灶切除的疗效进行了讨论。
出处
《肿瘤学杂志》
CAS
2008年第5期347-351,共5页
Journal of Chinese Oncology
参考文献65
-
1马建辉,何志嵩,万奔,等.肾细胞癌诊治指南[A].那彦群,孙则禹,叶章群,等.中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2007.8-29.
-
2Dekernion JB,Ramming KP,Smith RB.The natural history of metastatic renal cell carcinoma:a computer analysis[J].J Urol,1978,120(2):148-152.
-
3Motzer RJ,Bander NH,Nanus DM.Renal-cell carcinoma[J].N Engl J Med,1996,335(12):865-875.
-
4Blute ML,Leibovich BC,Cheville JC,et al.A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma[J].J Urol,2004,172(2):465-469.
-
5Pantuck AJ,Zisman A,Dorey F,et al.Renal cell carcinoma with retroperitoneal lymph nodes:role of lymph node dissection[J].J Urol,2003,169(6):2076-2083.
-
6Jocham D,Richter A,Hoffmann L,et al.Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy:phase Ⅲ,randomised controlled trial[J].Lancet,2004,363(9409):594-599.
-
7Bassil BA,Dosoretz DE,Prout GR.Validation of the tumor,nodes,and metastasis classification of renal cell carcinoma[J].J Urol,1985,134(3):450-454.
-
8Phillips CK,Taneja SS.The role of lymphadenectomy in the surgical management of renal cell carcinoma[J].Urol Oncol,2004,22(3):214-224.
-
9Paul R,Mordhorst J,Busch R,et al.Renal sparing surgery during radical nephrectomy in patients with renal cell cancer:a new algrithm[J].J Urol,2001,166(1):59-62.
-
10Siemer S,Lehmann J,Kamradt J,et al.Adrenal metastases in 1635 patients with renal cell carcinoma:outcome and indication for adrenalectomy[J].J Urol,2004,171(6 Pt 1):2155-2159.
同被引文献22
-
1张玲燕,汤永民,沈红强,宁铂涛,钱柏芹,石淑文,杨世隆,徐卫群.ABCG2在白血病细胞中的表达及其意义[J].浙江医学,2004,26(11):803-805. 被引量:3
-
2Negrier S. Better survival with interleukn-2-based regimens? Possibly only in highly selected patients [ J ]. J Clin Oncol, 2004, 22 : 1174 - 1176.
-
3Pavone L, Andrulli S,Santi R, et al. Long-term treatment with low doses of interleukn-2 and interferon-alpha: immunological effects in advanced renal cell cancer[ J]. Cancer Immunol Immunother, 2001, 50:82-86.
-
4Culine S, Iborra F, Mottet N, et al. Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma:Results of a French regional experience in Languedoc [ J ]. Am J Clin Oncol, 2006, 29(2) :148 -152.
-
5Martel CL, Lara PN. Renal cell carcinoma current status and future directions [J].Crit Rev Oncol Hematol, 2003, 45:177 - 190.
-
6Escudier B, Eisen T, Stadler WM, et al. Sorafenib in advanced dear-cell renal-cell carcinoma[ J ]. N Engl J Med, 2007, 356: 125 - 134.
-
7Motzer R J, Hutson TE, Tomczak P, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma [ J ]. N Engl J Med, 2007,356(2) :115 - 124.
-
8Hudes G, Cardueci M, Tomczak P, et al. Temsimlimus, interferon alfa, or both for advanced renal-cell carcinoma[J].N Engl J Med, 2007, 356:2271 - 2281.
-
9Maisey NR, Hall K, Lee C, et al. Infliximab. A phase Ⅱ trial of the tumor necrosis factor(TNFα) monoclonal antibody in patients with advanced renal cell cancer( RCC ) [ J ]. J Clin Oncol,2004, 22 : a4514.
-
10成波(综述),韩瑞发(审校).肾癌预后分子标记物的研究进展[J].国际泌尿系统杂志,2007,27(5):624-628. 被引量:6
引证文献3
-
1王美清,彭大为,程小珍,周宇,莫小翠.低剂量白介素-2联合干扰素-α治疗转移性肾癌[J].临床肿瘤学杂志,2009,14(9):818-822. 被引量:3
-
2马稔翌,罗方秀,赵菊平,何竑超,王浩飞,黄欣,孙福康,徐兆平,周文龙,祝宇,沈周俊.ABCG2在肾细胞癌临床随访中的意义[J].临床泌尿外科杂志,2016,31(11):986-990.
-
3韩静,董志红,蒲艳,宋建忠,张萌萌,柳惠斌.NDUFA4L2在肾透明细胞癌组织与外周血中的表达及意义[J].山东医药,2019,59(28):60-63. 被引量:1
二级引证文献4
-
1郑振东,屈淑贤,刘永,叶郝辉,章国晶,谢晓冬.晚期肾癌一线治疗的临床对照研究[J].中华医学杂志,2012,92(42):2984-2987. 被引量:5
-
2李伟梁建波,李伟,梁建波.干扰素体外干预对肾癌组织STAT1和P-STAT1表达的影响[J].天津医药,2013,41(10):1012-1013. 被引量:2
-
3赵玥,吴瑾.转移性肾癌的内科治疗及相关研究进展[J].癌症进展,2018,16(7):807-811. 被引量:15
-
4刘彤崴,李良,王卓,陈静.miR-183-5p和NDUFA4L2在肾透明细胞癌中的表达及相关性[J].中国医科大学学报,2023,52(4):327-332. 被引量:2
-
1李勉洲,贾月峰,王沛涛,牛海涛,姜海平,王新生.外科联合靶向治疗在肾细胞癌中的应用[J].国际泌尿系统杂志,2015,35(3):428-431. 被引量:1
-
2王琦,于德新.局部进展性肾癌综合治疗的研究进展[J].临床泌尿外科杂志,2012,27(12):952-955.
-
3李顺,张毅,李博,赵庆利,李青.树突状细胞免疫治疗用于局部进展性肾癌根治术患者效果观察[J].山东医药,2010,50(39):11-13. 被引量:1
-
4张红霞,王宏远,申宝忠,曲丽英,于树江.CT诊断胃癌的临床价值[J].实用肿瘤学杂志,2002,16(4):262-264. 被引量:1
-
5李海波,王禾,武国军.EZH2基因在肾透明细胞癌中的表达及其意义[J].西安交通大学学报(医学版),2009,30(2):218-220. 被引量:4
-
6王慧萍,徐蕾,宋黎明,于和鸣,邢念增.前列腺特异性膜抗原在前列腺癌患者外周血和组织中的表达及意义[J].中国肿瘤临床与康复,2010,17(2):104-106. 被引量:2
-
7王志平,马腾.局部进展性肾癌诊治进展[J].临床外科杂志,2015,23(2):87-90.
-
8王超,肖永红.彩色多普勒超声对肾细胞癌术前诊断的最新进展[J].医学美学美容(中旬刊),2014,23(5):692-693.
-
9黄双,孙圣坤,徐阿祥,张旭.吉西他滨联合卡铂治疗局部浸润性膀胱癌的疗效分析[J].现代生物医学进展,2013,13(17):3254-3257. 被引量:8
-
10Noterman D.,Philippson C.,Hertens D.,柳蕴.局部进展性宫颈癌的新辅助放化疗及手术治疗:对Bordet研究所治疗的22例患者的回顾研究(法)[J].世界核心医学期刊文摘(妇产科学分册),2006,0(8):61-61.